US

Kevin R Bracken


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Kevin R Bracken: Innovator in Antibiotic Formulation

Introduction

Kevin R Bracken is an accomplished inventor based in the United States. He has made significant contributions to the field of antibiotic formulations, particularly focusing on the treatment of bacterial infections. His innovative work has the potential to impact the medical community positively.

Latest Patents

Kevin R Bracken holds a patent for an antibiotic formulation and its use for bacterial infections. This patent describes a liposomal aminoglycoside formulation that comprises a neutrallipid, a negatively charged lipid, and a sterol. The formulation contains unilamellar vesicles with an average size below 100 nm. Additionally, the patent outlines a process for making liposomes containing an aminoglycoside and a method for treating both drug-susceptible and drug-resistant bacteria.

Career Highlights

Kevin R Bracken is currently associated with Amplimed, Inc., where he continues to develop innovative solutions in the field of antibiotics. His work is characterized by a commitment to addressing the challenges posed by bacterial infections.

Collaborations

Some of his notable coworkers include Evan M Hersch and Eskild A Petersen. Their collaborative efforts contribute to the advancement of research and development in antibiotic formulations.

Conclusion

Kevin R Bracken's contributions to antibiotic formulation represent a significant advancement in the fight against bacterial infections. His innovative approach and dedication to research continue to pave the way for future developments in this critical area of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…